AC Immune S.A. (ACIU) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 250.92M |
| Enterprise Value | 228.64M |
| P/E Ratio | -2.68 |
| PEG Ratio | 0.07 |
| Price/Sales Ratio | 48.64 |
| Price/Book Ratio | 5.54 |
| Enterprise/Revenue | 44.62 |
| Enterprise/EBITDA | -2.56 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -17.89 |
| Operating Margin | -17.49 |
AD
Management Effectiveness
| Return On Assets | -0.48 |
| Return On Equity | -1.24 |
Income Statement
| Revenue | 3.57M |
| Revenue/Share | 0.04 |
| Gross Profit | 3.57M |
| EBITDA | -67.75M |
| Net Income | -70.45M |
| Diluted EPS | -0.7 |
Balance Sheet
| Total Cash | 74.8M |
| Total Cash/Share | 0.76 |
| Total Debt | 4.3M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 0.87 |
| Book Value Per Share | 0.32 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 4 |
| 52-Week Low | 2.03 |
| Moving Average 50 Days | 2.43 |
| Moving Average 200 Days | 2.91 |
Statistics
| Average Volume | 268,740 |
| Shares Outstanding | 101.77M |
| % Held by Institutions | 25.42 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
